Search

Herbert, D.G., Hamer, M.L., Mander, M., Mkhize, N., Prins, F., . (2003): Invertebrate animals as a component of the traditional medicine trade in KwaZulu-Natal, South Africa. African Invertebrates 44 (2): 1-18, DOI: http://doi.org/10.5281/zenodo.7666422, {"references":["ALINO, P. M., CAJIPE, G. J. B., GANZON- FORTES, E. T., LICUANAN, W. R. Y., MONTANO, N. E. & TUPAS, L. M. 1990. The use of marine organisms in folk medicine and horticulture: a preliminary study. Philippines: Seaweed Information Centre, Leaflet 1.","ARNOLD, H-J. & GULUMIAN, M. 1984. Pharmacopoeia of traditional medicine in Venda. Journal of Ethnopharmacology 12: 35-74.","BERGLUND, A-I. 1976. Zulu thought-patterns and symbolism. Cape Town: David Philip, for Swedish Institute of Missionary Research, Uppsala.","BERLIN, B. 1973. Folk systematics in relation to biological classification and nomenclature. Annual Review of Ecology and Systematics. 4: 259-271.","BERLIN, B. 1992. Ethnobiological classification. Princeton: Princeton University Press.","BENTLEY,A. C. & COCKCROFT,A. C. 1995. Sand dollar (Echinodiscus bisperforatus) distribution and abundance in South Africa:Implications for conservation and legislation. South African Journal of Science 91: 38-40.","BOSSARD, E. 1996. La medecine traditionelle au centre et a l'ouest de l'Angola. Lisbon: Instituto de Investigacao Cientifica Tropical.","BRANCH, G. M., GRIFFITHS, C. L., BRANCH, M. L. & BECKLEY, L. E. 1994. Two Oceans. A guide to the marine life of southern Africa. Cape Town: David Philip.","BRYANT, A. T. 1966. Zulu medicine and medicine-men. Cape Town: Struik.","CHUNG, P-R., PARK, G-M., JUNG, Y., YONG, T-S., IM, K-I. & SOH, C-T. 2000. Medicinal molluscs in Korea. Korean Journal of Malacology 16 (1-2): 55-60.","CLARE, A. S. 1996. Marine natural product antifoulants: status and potential. Biofouling 9: 211-229.","CLARK, T., CROUCH, N. & NGWENYA, A. 1996. Ibhungezi - the Afro-Spanish fly. Africa Environment and Wildlife 4 (5): 8.","CUNNINGHAM,A.B. & ZONDI, A. S. 1991. Use of animal parts for the commercial trade in traditional medicines. Pietermaritzburg: Institute of Natural Resources. (working paper No. 76).","DAVIES- COLEMAN, M. 1996. Marine invertebrate bioprospecting in South Africa. SANCOR Newsletter 145: 4-5.","DERWENT, S. & MANDER, M. 1997. Twitchers bewitched: The use of birds in traditional healing. Africa: Birds & Birding 2 (1): 22-25.","FINGERMAN, M. & NAGABHUSHANAM, R. 2001. eds, Bio-organic compounds: chemistry and biomedical applications. Recent Advances in marine Biotechnology 6.","FOURIE, T. G., SWART, I. & SNYCKERS, F. O. 1992. Folk medicine: a viable starting point for pharmaceutical research. South African Journal of Science 88: 190-193.","HAMMOND- TOOKE, D. 1989. Rituals and medicines. Johannesburg: Ad. Donker.","HIGA, T., TANAKA, J., OHTANI, I. I., MUSMAN, M., ROY, M. C. & KURODA, I. 2001. Bioactive compounds from coral reef invertebrates. Pure and Applied Chemistry 73 (3): 589-593.","ICZN 1999. International Code of Zoological Nomenclature. Fourth ed'n London: International Trust for Zoological Nomenclature.","IRELAND, C. M., ROLL, D. M., MOLINSKI, T. F., MCKEE, T.C., ZABRISKIE, T.M. & SWERSEY, J. J. 1988. Uniqueness of the marine chemical environment: categories of marine natural products from invertebrates. In: Fautin. D. G. ed., Biomedical importance of marine organisms. San Francisco: California Academy of Sciences, pp. 41-52.","JUNOD, H. A. 1927. The life of a South African tribe. Vol. II. Mental Life. London: Macmillan (reprinted 1962. New York: University Books).","KALK, M. 1995. Sea meadows and sand banks on the subtidal fringe. In: Kalk, M. ed., A natural history of Inhaca Island Mozambique. Johannesburg: Witwatersrand University Press, pp. 247-275.","KYLE, R., PEARSON, B., FIELDING, P. J., ROBERTSON, W. D. & BIRNIE, S. L. 1997.Subsistence shellfish harvesting in the Maputaland marine reserve in northern KwaZulu-Natal, South Africa: rocky shore organisms. Biological Conservation 82: 183-192.","MACDONALD, I. A. W. 1984. Witchdoctors versus wildlife in South Africa. African Wildlife 38 (1): 2-9.","MANDER, M. 1998. Marketing of indigenous medicinal plants in South Africa. Rome: FAO.","MAYER, A. M. S. 1999. Marine pharmacology in 1998: antitumor and cytotoxic compounds. The Pharmacologist 41 (4): 159-164.","MCKEAN, S. G. 1995. A directory of animal species used for traditional medicine in KwaZulu-Natal. Pietermaritzburg: Natal Parks Board internal report.","NGUBANE, H. 1977. Body and mind in Zulu medicine. London: Academic Press.","OLIVERA, B. M. & CRUZ, L. J. 2001. Conotoxins in retrospect. Toxicon 39 (1): 7-14.","PEMBERTON, R. W. 1999. Insects and other arthropods used as drugs in Korean traditional medicine. Journal of Ethnopharmacology 65: 207-216.","PLUG, I. 1987. An analysis of witchdoctor diving sets. Research Natco Museum 1 (3): 48-67.","SCHEUER, P. J. 1988. Ethno-natural historical leads. In: Fautin, D. G. ed. Biomedical importance of marine organisms. San Francisco: California Academy of Sciences, pp. 37-40.","SIMELANE, T. S. 1996.The traditional use of indigenous vertebrates. MSc thesis, University of Port Elizabeth.","SIMELANE, T. S. & KERLEY, G. I. H. 1998. Conservation implications of the use of vertebrates by Xhosa traditional healers in South Africa. South African Journal of Wildlife Research 28 (4): 121-126.","TANG, W. 1987. Chinese medicinal materials from the sea. Abstracts of Chinese Medicines 1 (4): 571-600.","WYNBERG, R. & LAIRD, S. 1997. The scramble for genes. Biodiversity prospecting in South Africa. Africa: Environment & Wildlife 5 (3): 53-59."]}

This study was performed to determine the localization of the recently described receptor for the globular domain of C1q, gC1qR. In contrast to previous reports, we were not able to detect significant surface expression of gC1qR on Raji cells, monocytes, neutrophils, human or rat mesangial cells, the endothelial cell line EA.hy 926, or HUVEC using FACS analysis. Only by using digoxigenin-conjugated Abs could some surface staining of gC1qR be observed on rat mesangial cells and neutrophils. However, after permeabilizing these cells with saponin, a strong positive intracellular staining for gC1qR was observed by FACS, fluorescence microscopy on coverslips, and confocal laser scanning microscopic analysis. By reflection contrast microscopy and electron microscopy on ultrathin sections of permeabilized Raji cells, it was shown that gC1qR is present in double membranous cytoplasmic vesicles located in the proximity of the plasma membrane. To determine whether certain conditions could induce surface expression of gC1qR, Raji cells were either stimulated with T cell growth factor, LPS, or driven to apoptosis by incubation with fenretinide or by serum depletion. None of the conditions resulted in significant surface expression of gC1qR. Our hypothesis that gC1qR is not a surface molecule but a soluble molecule that is secreted by cells is supported by the observation that gC1qR is found in significant concentrations in supernatants of several cultured cells and in normal human and rat sera. Our results suggest that the recently described gC1qR is not a cell surface receptor, but a soluble binding protein with affinity for the globular heads of C1q. Excreted gC1qR might act as a potential fluid phase regulator of complement activation.

This study was performed to determine the localization of the recently described receptor for the globular domain of C1q, gC1qR. In contrast to previous reports, we were not able to detect significant surface expression of gC1qR on Raji cells, monocytes, neutrophils, human or rat mesangial cells, the endothelial cell line EA.hy 926, or HUVEC using FACS analysis. Only by using digoxigenin-conjugated Abs could some surface staining of gC1qR be observed on rat mesangial cells and neutrophils. However, after permeabilizing these cells with saponin, a strong positive intracellular staining for gC1qR was observed by FACS, fluorescence microscopy on coverslips, and confocal laser scanning microscopic analysis. By reflection contrast microscopy and electron microscopy on ultrathin sections of permeabilized Raji cells, it was shown that gC1qR is present in double membranous cytoplasmic vesicles located in the proximity of the plasma membrane. To determine whether certain conditions could induce surface expression of gC1qR, Raji cells were either stimulated with T cell growth factor, LPS, or driven to apoptosis by incubation with fenretinide or by serum depletion. None of the conditions resulted in significant surface expression of gC1qR. Our hypothesis that gC1qR is not a surface molecule but a soluble molecule that is secreted by cells is supported by the observation that gC1qR is found in significant concentrations in supernatants of several cultured cells and in normal human and rat sera. Our results suggest that the recently described gC1qR is not a cell surface receptor, but a soluble binding protein with affinity for the globular heads of C1q. Excreted gC1qR might act as a potential fluid phase regulator of complement activation.

The polycystic kidney disease-1 gene, which is mutated in the majority of patients with autosomal dominant polycystic kidney disease, has been identified. The protein encoded by this gene, polycystin, has no homology with any gene known thus far. To gain more insight into the function of polycystin, we raised antibodies against synthetic peptides and a fusion protein corresponding to the sequence of two different fragments of polycystin. Two of the antibodies were capable of immunoprecipitating an in vitro transcription and translation product corresponding to a fragment of polycystin. In the cyst-lining epithelium of polycystic kidney disease-1 patients, a strong staining was observed. In normal adult and embryonic kidney tissues, expression was seen in the epithelium of all tubular structures and in the glomerular parietal and visceral epithelium (podocytes), although the podocytes were mainly recognized on cryosections and not on paraffin sections. A double-labeled immunofluorescence with one of the polycystin antibodies and the monoclonal antibody 8G8 ascertained that within the glomerular tuft podocytes were recognized.

The development of glomerulosclerosis was studied in murine chronic graft-versus-host disease (GvHD), which is a model for human systemic lupus erythematosus. The authors investigated the distribution patterns of six components of the extracellular matrix (ECM), i.e., laminin, fibronectin, collagen types I, III, IV, and VI during the course of the disease. All of these ECM components except collagen type I were found in the glomeruli of normal mice, where all of them were intrinsic constituents of the mesangium. Laminin, fibronectin, and collagen type IV were also found in the glomerular capillary walls. Starting 6 weeks after the induction of GvHD and continuing at week 8, the onset of an expansion of the mesangial matrix was observed. At the same time, the amounts of laminin, fibronectin, and collagen types IV and VI increased. Ten weeks after the onset of the disease, glomerulosclerosis developed. Traces of the interstitial collagen type I were found in sclerotic glomeruli. The levels of four ECM components, i.e., collagens III, IV, VI, and laminin were markedly decreased in the sclerotic glomeruli as compared with week 8. In contrast, the amount of fibronectin in the sclerotic glomeruli increased dramatically. Immunoelectron microscopic examination showed fibronectin in the sclerotic lesions, in contrast to laminin, collagen type I, and collagen type IV. It is concluded that the sclerotic lesions in murine chronic GvHD contain fibronectin. The small amounts of the ECM components laminin, as well as collagens III, IV, and VI in the sclerotic glomeruli in GvHD, might represent remnants of mesangial material and collapsed capillary walls. These components are probably replaced by increased production and/or accumulation of collagen type I and fibronectin.